Dr. Meenakshi Dhanawat is an Associate Professor at the Amity Institute of Pharmacy, Amity University Haryana, with many years of experience in Pharmaceutical Sciences and Medicinal Chemistry. She completed her Master's degree at NIPER, Mohali, focusing on glycosylamino acids, and earned her Ph.D. from IIT-BHU, Varanasi, investigating CNS drug delivery targeting 5HT1A/2A receptors. Her research encompasses synthetic and heterocyclic chemistry, nanotechnology, drug delivery systems, prodrug design, complexation, polymer chemistry, and herbal drug extraction. Dr. Dhanawat has received notable international recognition, including a travel grant from the AAPS Drug Delivery and Development section for the 2010 National Biotechnology Conference in California, and international travel grants from DBT and DST, Government of India, for conferences in California and Munich. Her distinguished honors include the Rajiv Gandhi National Fellowship, affirming her sustained contributions to pharmaceutical research and academic excellence. Dr. Inderjeet Verma is a Professor and Head of Pharm.D at M.M. College of Pharmacy, with over 16 years of experience in pharmacology and drug development. His research spans clinical pharmacology, rheumatology, and experimental therapeutics, with a focus on autoimmune and inflammatory diseases. He has published extensively and holds a UK patent on a medical UV device. His work emphasizes translational research, molecular signaling pathways, and innovative drug therapies for autoimmune disorders. His expertise in pharmacodynamics and clinical pharmacology supports the development of targeted treatments such as JAK inhibitors and signaling pathways in disease management.

• 1. Role of JAK-STAT Signaling in Physiology: Immunity and Homeostasis2. JAK-STAT Targeted Therapy in Immunology: Advances and Prospects3. Unraveling the JAK-STAT in Rheumatoid Arthritis4. Innovations in JAK-STAT Targeted Medicine Development of Inflammatory Bowel Disease5. Role of the JAK-STAT Pathway in Dermatologic Diseases: Pathophysiology and Therapeutic Implications6. Exploring the Role of JAK/STAT Signaling in Osteoarthritis Progression7. The JAK-STAT Pathway as a Novel Antiviral Target: Mechanisms and Therapeutic Prospect8. Exploring the JAK/STAT Pathway in Metabolic Disorders: Obesity and Diabetes9. JAK Inhibitors for Respiratory Disorders10. Deciphering JAK/STAT Signaling Roles in Tumorigenesis and Therapeutic Targeting11. Neuroinflammation and Neurological Disorders: The Rescue of the JAK/STAT Signaling Cascade12. Pediatric Applications and Considerations of JAK Inhibition13. Exploring the Integration of JAK/STAT with Other Signaling Pathways in Health and Disease